FILTER

LATEST INTERVIEWS

Tom Sellig

CEO, ADARE PHARMA SOLUTIONS
"Our reputation is based on how we deploy technologies to solve complex formulation challenges."

Mark Jara

PRINCIPAL AND MANAGING DIRECTOR, RXS
"Tele-health tactics gained momentum and our clients made their pivot, like other industries, to fully remote operations. RxS, with our technology-forward approach, was prepared for the shift."

Danny Foong

GENERAL MANAGER, ARKEMA SOUTHEAST ASIA
Arkema updates GBR on its investments in Singapore.

Law Gee Yong

DIRECTOR OF POLICY & PLANNING DEPARTMENT, ENERGY MARKET AUTHORITY
The Energy Market Authority’s (EMA) main goals are to ensure a reliable and secure energy supply, promote effective competition in the energy market and develop a dynamic energy sector in Singapore.

Conrad Karageorge

CEO, AMANI GOLD
Amani Gold updates GBR on progress at its Giro gold project in DRC.

Oliver Dallaway

DIRECTOR DRC, AFRICAN MINING SERVICES (AMS)
AMS comments on serving mines and mining contractors in the DRC.

Candice Long

PRESIDENT – US INFECTIOUS DISEASES & VACCINES, JANSSEN PHARMACEUTICALS
"In vaccines, we are progressing late-stage programs of break-through vaccines against diseases where vaccines are not currently available, such as RSV and multidrug resistant bacterial infections, including ExPEC and Staphylococcus aureus."

Joe Panetta

PRESIDENT & CEO, BIOCOM CALIFORNIA
"We experienced explosive growth across the state and consequently adopted a new name: Biocom California."

Renaud Adams

PRESIDENT & CEO, NEW GOLD INC.
New Gold updates GBR on progress at its Rainy River and New Afton mines

Andrew Taylor

PRESIDENT, GROWTH MARKETS, (ASIA, MIDDLE EAST, AFRICA, AND LATIN AMERICA) TATE & LYLE
Tate & Lyle is now transformed into a purpose-led, growth-focused global food and beverage solutions business, serving faster growing specialty markets.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2022

PARTNER EVENTS